"Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis." Neurology
97.16
(2021):
e1546-e1559.
Web. 31 Mar. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
